Caxton Associates (New York)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,591
Closed -$893K 752
2022
Q1
$893K Buy
+14,591
New +$893K 0.07% 106